Delray Beach, Fla. – September 17, 2026 -- The global pipette calibration services market is projected to more than double to USD 834.8 million by 2031 from USD 383.2 million in 2026, a 16.9% compound annual growth rate, according to MarketsandMarkets.
North America controls half of global demand as regulatory pressure mounts
North America held a 50.6% share of the pipette calibration services market in 2025, underpinned by dense pharmaceutical and biotechnology infrastructure, federal biomedical research funding, and strict laboratory equipment qualification requirements. Thermo Fisher Scientific, Eppendorf, and Sartorius operate significant service footprints across the region, supporting clinical labs, academic institutions, and drug manufacturers requiring traceable measurement accuracy.
Hybrid calibration programs post fastest growth as labs cut downtime
On-site calibration led the market by service type in 2025, favored by pharmaceutical, biotech, and testing laboratories seeking to avoid shipping instruments and disrupting workflows. Hybrid programs, which combine on-site and off-site elements, are forecast to grow fastest at 17.7% CAGR through 2031 as high-throughput, automated liquid-handling systems raise demand for rapid, flexible calibration.
Independent metrology labs gain share from OEM-affiliated providers
OEM/manufacturer-affiliated providers dominated the service-provider segment in 2025, but independent third-party metrology labs are set for the fastest growth. Their ISO/IEC 17025-accredited, multi-brand calibration capabilities let pharmaceutical companies and clinical laboratories consolidate maintenance across a single vendor rather than manufacturer-specific channels.
Transcat completes $84 million Essco acquisition, its largest deal ever
Transcat acquired Essco Calibration Laboratory for USD 84 million in cash in August 2025, the largest acquisition in the company's history. Essco generated more than USD 22 million in annual revenue providing in-house and on-site calibration to medical and life sciences customers; the deal was backed by a newly established USD 150 million syndicated credit facility led by M&T Bank and Wells Fargo.
Transcat had previously acquired Martin Calibration Inc. for USD 79 million in December 2024, comprising USD 69 million in cash and USD 10 million in company stock, expanding its ISO 17025-accredited laboratory network for medical and life sciences clients. In April 2026, Transcat acquired SCM Metrology and Laboratories S.A., extending its calibration-services footprint into Costa Rica and Latin America.
Electronic pipette adoption and CRO demand reshape service portfolios
The electronic/motorized instrument segment is expected to post the highest CAGR among instrument types, while CRO/CDMO end users are forecast to grow fastest among customer segments. Eppendorf SE, Sartorius AG, and Thermo Fisher Scientific Inc. hold leading market share globally, while Accredited Labs and Dlab Scientific have built strong positions in specialized niche segments.